Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Ethicon study shows benefits of SURGICEL

October 7, 2014 By AxoGen, Inc.

Ethicon, Inc. announced results of a large, retrospective study that showed the use of the SURGICEL® Family of Topical Absorbable Hemostats was associated with lower costs, reduced product usage, shortened length of hospital stay, and reduced transfusions compared to the use of other adjunctive hemostats.

The study was presented at the Society for the Advancement of Blood Management annual meeting in Houston, Texas.

The study results suggest that hospitals may improve patient outcomes and limit the overall cost of treatment by making the appropriate selection of hemostatic agents to minimize blood loss and potentially prevent complications from re-bleeding during surgery.

Hard-to-control, poorly controlled and uncontrolled bleeding in the surgical setting can have severe consequences, such as transfusions, increased length of stay and up to a 93 percent increase in costs. Adjunctive hemostats are typically utilized to reduce or prevent surgical bleeding, and over time, the use of hemostatic agents has increased for all surgical procedures.

“During the last 50 years, the SURGICEL® Family of Hemostats has consistently proven to be safe and effective with superb absorbability and in vitro bactericidal properties,” said Jerome Riebman, M.D., director, Medical Affairs at Ethicon. “This study adds to the growing body of evidence that suggests the SURGICEL® Family of Topical Absorbable Hemostats has the potential to reduce burdens associated with bleeding and bleeding-related complications, which translates into cost and resource use savings for health care providers.”

In June, a different study presented at the International Society on Thrombosis and Haemostasis showed that the use of advanced SURGICEL® products (SURGICEL® FIBRILLAR™ and SURGICEL®SNOW™) was associated with lower costs, reduced product usage, reduced length of hospital stay and reduced units of blood transfusions compared to SURGICEL® Original. These data provide further evidence of the efficacy of the SURGICEL® Family of Products, as well as its potential to positively impact patient outcomes and hospital resource use and cost.

Used in more than 100 million procedures, SURGICEL® ORIGINAL is considered to be the gold-standard comparator in topical absorbable hemostat clinical trials. Designed to meet evolving surgical needs, our advanced SURGICEL® FIBRILLAR™ and SURGICEL® SNOW™ brands enable surgeons to do more in the operating room while saving more.

The SURGICEL® Family of Hemostats are the first and only absorbable hemostats in the United States with proven bactericidal properties against more strains of bacteria than any other cellulose-based topical adjunctive hemostat, including various antibiotic-resistant bacteria (MRSA, VRE, PRSP and MRSE). Only SURGIGEL® Absorbable Hemostats demonstrate consistent bactericidal activity in vitro against the top five pathogens commonly reported to cause surgical site infections.

Read more at www.surgicel.com.

Related Articles Read More >

Avail Medsystems
How Avail Medsystems seeks to create a connected OR experience
Engineer inspecting artificial hip joint parts in quality control department in orthopaedic factory
Deburring and finishing for beautiful, functional medical devices
FDA logo
FDA seeking innovations to move beyond heater-cooler device problems
Logos of Creo Medical and Intuitive
Creo Medical inks collaboration agreement with Intuitive

DeviceTalks Weekly.

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech